Passage Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
PHILADELPHIA, April 21, 2023 (GLOBE NEWSWIRE) -- Passage Bio, Inc. PASG, a clinical-stage genetic medicines company focused on developing transformative therapies for central nervous system (CNS) disorders, today announced it has granted an inducement …